Chargement en cours...
CMET-36. BEVACIZUMAB WITH OR WITHOUT LOMUSTINE FOR METASTATIC ORBITAL, DURAL AND LEPTOMENINGEAL ESTHESIONEUROBLASTOMA
Esthesioneuroblastoma is a malignant neuroectodermal tumor originating from the olfactory neuroepithelium. Bevacizumab is a specific inhibitor of the vascular endothelial growth factor ligand, preventing its interaction with receptors on endothelial cells. Lomustine is a widely used alkylating agent...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216982/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.246 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|